Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)
Condition(s):Malignant Pleural MesotheliomasLast Updated:June 1, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Malignant Pleural MesotheliomasLast Updated:June 1, 2016Completed
Condition(s):Mesotheliomas PleuralLast Updated:January 26, 2021Not yet recruiting
Condition(s):Pleural Mesothelioma; Asbestos Exposure; Pleural PlaqueLast Updated:May 13, 2020Suspended
Condition(s):Malignant Pleural MesotheliomaLast Updated:June 9, 2017Completed
Condition(s):Malignant Pleural MesotheliomaLast Updated:November 17, 2020Withdrawn
Condition(s):Malignant Pleural MesotheliomaLast Updated:April 11, 2007Completed
Condition(s):Malignant Pleural Mesothelioma, Advanced; Malignant Pleural Mesothelioma, UnresectableLast Updated:December 26, 2018Not yet recruiting
Condition(s):Mesotheliomas PleuralLast Updated:December 23, 2020Not yet recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:August 25, 2020Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:August 6, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.